This site is intended for healthcare professionals

Phase IIb/III SELECTION trial shows efficacy of filgotinib for the induction and maintenance of remission in moderately and severely active ulcerative colitis.- Galapagos NV + Gilead Sciences

Read time: 2 mins
Last updated:13th Oct 2020
Published:13th Oct 2020
Condition: Ulcerative Colitis
Type: drug
Register free for full access to